TBXU
Direxion Daily Biotech Top 5 Bull 2X ETF
TBXU
Closed
$44.37
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
TBXU was created on 2025-10-01 by Direxion. The fund's investment portfolio concentrates primarily on health care equity. TBXUis passively managed, providing 2x leveraged exposure to an equally-weighted index of the top 5 largest US companies in thebiotechnologysub-industry.
Company
Direxion
Asset class
Equity
Inception date
2025
Investment segment
Health Care
ISIN
US25461H1014
Website
Key stats
Open
$43.74
Volume
6.14K
AUM
$5.60M
Prev. close
$44.41
Expense ratio
0.98%
P/E
0.00
$43.74
Day’s Range
$45.10
$27.00
52W Range
$45.10
What’s in the fund
12
Total holdings
Goldman Finl Sq Trsry Inst 506
16.75%
Regeneron Pharmaceuticals Inc
13.65%
Amgen Inc
12.43%
Vertex Pharmaceuticals Inc
12.36%
Gilead Sciences Inc
11.71%
argenx SE ADR
11.52%
Dx D Biotech T 5 Bull 2x Etf Swap
9.85%
Dreyfus Govt Cash Man Ins
7.78%
Dx D Biotech T 5 Bull 2x Etf Swap
4.99%
Others
-1.04%
Returns
Performance
_
Difference
_
Direxion Daily Biotech Top 5 Bull 2X ETF
Jun
30
Dividends
The last payment date was Jun 30, 2026
Div. per Share
$0.11
Div. Yield
0.25%
Div. Growth YoY
12.21%
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply